Crunch Time For Aerie At EMA
An EU Marketing Recommendation Could Be In Store For New Glaucoma Treatment
Aerie is already exploring its pricing strategy for Roclanda as the European Medicines Agency this week decides whether the intraocular pressure treatment should be approved in Europe.
You may also be interested in...
The European Medicines Agency this week recommended that five new products be granted EU marketing approval.
Companies have the opportunity to tell the European Commission what they think about its proposed regulation that would overhaul the rules governing the use of substances of human origin.
Leniolisib has become the first product to be granted accelerated assessment status by the European Medicines Agency this year.